$125.49
3.693.03%
At Close: -
$125.54
0.050.04%
After Hours: 6:47 PM EDT
15 minutes delayed
Comments
Loading...
Qorvo
QRVONASDAQ
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Qorvo (NASDAQ:QRVO) Stock, Analyst Ratings, Price Targets, Forecasts
Qorvo Inc has a consensus price target of $113.43 based on the ratings of 31 analysts. The high is $155 issued by Raymond James on May 5, 2022. The low is $78 issued by Citigroup on October 10, 2023. The 3 most-recent analyst ratings were released by Susquehanna, Rosenblatt, and Needham on July 17, 2024, June 12, 2024, and June 12, 2024, respectively. With an average price target of $120 between Susquehanna, Rosenblatt, and Needham, there's an implied -4.41% downside for Qorvo Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Susquehanna
Rosenblatt
Needham
Goldman Sachs
Barclays
1calculated from analyst ratings
Analyst Ratings for Qorvo
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/17/2024 | Buy Now | 15.5% | Susquehanna | Christopher Rolland | $95 → $145 | Maintains | Neutral | Get Alert |
| 06/12/2024 | Buy Now | -16.36% | Rosenblatt | Kevin Cassidy | $105 → $105 | Maintains | Neutral | Get Alert |
| 06/12/2024 | Buy Now | -12.38% | Needham | Quinn Bolton | $110 → $110 | Reiterates | Buy → Buy | Get Alert |
| 05/03/2024 | Buy Now | -16.36% | Goldman Sachs | Toshiya Hari | $117 → $105 | Maintains | Neutral | Get Alert |
| 05/02/2024 | Buy Now | -20.34% | Barclays | Tom O'Malley | $110 → $100 | Maintains | Equal-Weight | Get Alert |
| 05/02/2024 | Buy Now | -20.34% | JP Morgan | Peter Peng | $105 → $100 | Maintains | Underweight | Get Alert |
| 05/02/2024 | Buy Now | 1.96% | Benchmark | Cody Acree | $136 → $128 | Maintains | Buy | Get Alert |
| 05/02/2024 | Buy Now | -24.33% | Susquehanna | Christopher Rolland | $100 → $95 | Maintains | Neutral | Get Alert |
| 05/02/2024 | Buy Now | -16.36% | Mizuho | Vijay Rakesh | $115 → $105 | Maintains | Neutral | Get Alert |
| 05/02/2024 | Buy Now | -12.38% | Needham | Quinn Bolton | $125 → $110 | Maintains | Buy | Get Alert |
| 04/08/2024 | Buy Now | -20.34% | Susquehanna | Christopher Rolland | → $100 | Maintains | Neutral | Get Alert |
| 02/02/2024 | Buy Now | -6.8% | Goldman Sachs | Toshiya Hari | $104 → $117 | Maintains | Neutral | Get Alert |
| 02/01/2024 | Buy Now | -16.36% | Piper Sandler | Harsh Kumar | $120 → $105 | Maintains | Neutral | Get Alert |
| 02/01/2024 | Buy Now | -16.36% | Rosenblatt | Kevin Cassidy | $95 → $105 | Maintains | Neutral | Get Alert |
| 02/01/2024 | Buy Now | -4.41% | Raymond James | Srini Pajjuri | $115 → $120 | Maintains | Outperform | Get Alert |
| 02/01/2024 | Buy Now | -16.36% | JP Morgan | Bill Peterson | $95 → $105 | Maintains | Underweight | Get Alert |
| 02/01/2024 | Buy Now | -6.8% | Goldman Sachs | Toshiya Hari | $104 → $117 | Maintains | Neutral | Get Alert |
| 02/01/2024 | Buy Now | -0.43% | Needham | Quinn Bolton | → $125 | Reiterates | Buy → Buy | Get Alert |
| 01/19/2024 | Buy Now | -8.4% | Raymond James | Srini Pajjuri | $105 → $115 | Maintains | Outperform | Get Alert |
| 01/16/2024 | Buy Now | -20.34% | Barclays | Tom O'Malley | $95 → $100 | Maintains | Equal-Weight | Get Alert |
| 01/04/2024 | Buy Now | -4.41% | Piper Sandler | Harsh Kumar | → $120 | Downgrade | Overweight → Neutral | Get Alert |
| 12/08/2023 | Buy Now | 6.74% | Morgan Stanley | Joseph Moore | $120 → $134 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 11/03/2023 | Buy Now | -20.34% | BMO Capital | Ambrish Srivastava | $110 → $100 | Maintains | Market Perform | Get Alert |
| 11/03/2023 | Buy Now | -22.73% | Mizuho | Vijay Rakesh | $107 → $97 | Maintains | Neutral | Get Alert |
| 11/02/2023 | Buy Now | -24.33% | JP Morgan | Bill Peterson | $110 → $95 | Maintains | Underweight | Get Alert |
| 11/02/2023 | Buy Now | -4.41% | Morgan Stanley | Joseph Moore | $116 → $120 | Maintains | Equal-Weight | Get Alert |
| 11/02/2023 | Buy Now | -16.36% | Raymond James | Srini Pajjuri | $125 → $105 | Maintains | Outperform | Get Alert |
| 11/02/2023 | Buy Now | -24.33% | Barclays | Blayne Curtis | $110 → $95 | Maintains | Equal-Weight | Get Alert |
| 11/02/2023 | Buy Now | — | Summit Insights Group | Kinngai Chan | — | Downgrade | Buy → Hold | Get Alert |
| 10/24/2023 | Buy Now | -24.33% | Susquehanna | Christopher Rolland | $110 → $95 | Maintains | Neutral | Get Alert |
| 10/10/2023 | Buy Now | -37.87% | Citigroup | Atif Malik | $116 → $78 | Downgrade | Neutral → Sell | Get Alert |
| 08/03/2023 | Buy Now | -0.43% | Raymond James | Srini Pajjuri | $120 → $125 | Maintains | Outperform | Get Alert |
| 08/03/2023 | Buy Now | -7.6% | Morgan Stanley | Joseph Moore | $111 → $116 | Maintains | Equal-Weight | Get Alert |
| 08/03/2023 | Buy Now | -12.38% | Wells Fargo | Gary Mobley | $100 → $110 | Maintains | Equal-Weight | Get Alert |
| 08/03/2023 | Buy Now | -12.38% | Susquehanna | Christopher Rolland | $105 → $110 | Maintains | Neutral | Get Alert |
| 08/03/2023 | Buy Now | -24.33% | Rosenblatt | Kevin Cassidy | → $95 | Reiterates | Neutral → Neutral | Get Alert |
| 08/03/2023 | Buy Now | -0.43% | Needham | Rajvindra Gill | → $125 | Reiterates | Buy → Buy | Get Alert |
| 08/03/2023 | Buy Now | 7.54% | Exane BNP Paribas | Karl Ackerman | → $135 | Upgrade | Neutral → Outperform | Get Alert |
| 07/20/2023 | Buy Now | -0.43% | Wolfe Research | Chris Caso | → $125 | Initiates | → Outperform | Get Alert |
| 07/19/2023 | Buy Now | -32.29% | Rosenblatt | Kevin Cassidy | → $85 | Reiterates | Neutral → Neutral | Get Alert |
| 06/22/2023 | Buy Now | -18.75% | Mizuho | Vijay Rakesh | → $102 | Reiterates | Neutral → Neutral | Get Alert |
| 05/05/2023 | Buy Now | -17.95% | Citigroup | Atif Malik | $113 → $103 | Maintains | Neutral | Get Alert |
| 05/04/2023 | Buy Now | -12.38% | BMO Capital | Ambrish Srivastava | $105 → $110 | Maintains | Market Perform | Get Alert |
| 05/04/2023 | Buy Now | -11.58% | Morgan Stanley | Joseph Moore | $110 → $111 | Maintains | Equal-Weight | Get Alert |
| 05/04/2023 | Buy Now | 11.52% | Needham | Rajvindra Gill | $130 → $140 | Maintains | Buy | Get Alert |
| 05/04/2023 | Buy Now | — | Summit Insights Group | Kinngai Chan | — | Upgrade | Hold → Buy | Get Alert |
| 05/04/2023 | Buy Now | -18.75% | Mizuho | Vijay Rakesh | $100 → $102 | Maintains | Neutral | Get Alert |
| 04/11/2023 | Buy Now | -20.34% | Wells Fargo | Gary Mobley | $110 → $100 | Maintains | Equal-Weight | Get Alert |
| 04/06/2023 | Buy Now | -12.38% | Stifel | Ruben Roy | → $110 | Initiates | → Hold | Get Alert |
| 03/02/2023 | Buy Now | -4.41% | Raymond James | Srini Pajjuri | → $120 | Reinstates | → Outperform | Get Alert |
| 02/03/2023 | Buy Now | -9.99% | Citigroup | Atif Malik | $94 → $113 | Maintains | Neutral | Get Alert |
| 02/03/2023 | Buy Now | -20.34% | Mizuho | Vijay Rakesh | $93 → $100 | Maintains | Neutral | Get Alert |
| 02/02/2023 | Buy Now | 3.55% | Craig-Hallum | Anthony Stoss | $120 → $130 | Maintains | Buy | Get Alert |
| 02/02/2023 | Buy Now | -20.34% | Cowen & Co. | Matthew Ramsay | $80 → $100 | Maintains | Market Perform | Get Alert |
| 02/02/2023 | Buy Now | -20.34% | Susquehanna | Christopher Rolland | $95 → $100 | Maintains | Neutral | Get Alert |
| 02/02/2023 | Buy Now | -16.36% | BMO Capital | Ambrish Srivastava | $90 → $105 | Maintains | Market Perform | Get Alert |
| 02/02/2023 | Buy Now | -20.34% | Mizuho | Vijay Rakesh | $93 → $100 | Maintains | Neutral | Get Alert |
| 02/02/2023 | Buy Now | -12.38% | Morgan Stanley | Joseph Moore | $87 → $110 | Maintains | Equal-Weight | Get Alert |
| 02/02/2023 | Buy Now | -12.38% | Wells Fargo | Gary Mobley | $90 → $110 | Maintains | Equal-Weight | Get Alert |
| 02/02/2023 | Buy Now | -4.41% | Piper Sandler | Harsh Kumar | $100 → $120 | Maintains | Overweight | Get Alert |
| 02/02/2023 | Buy Now | 3.55% | Needham | Rajvindra Gill | $105 → $130 | Maintains | Buy | Get Alert |
| 01/23/2023 | Buy Now | -12.38% | Barclays | Blayne Curtis | $85 → $110 | Maintains | Equal-Weight | Get Alert |
| 01/09/2023 | Buy Now | -28.31% | Wells Fargo | Gary Mobley | $80 → $90 | Maintains | Equal-Weight | Get Alert |
| 11/16/2022 | Buy Now | -4.41% | Credit Suisse | Chris Caso | → $120 | Initiates | → Outperform | Get Alert |
| 11/03/2022 | Buy Now | -28.31% | BMO Capital | Ambrish Srivastava | $100 → $90 | Maintains | Market Perform | Get Alert |
| 11/03/2022 | Buy Now | -16.36% | Needham | Rajvindra Gill | $100 → $105 | Maintains | Buy | Get Alert |
| 11/03/2022 | Buy Now | -30.7% | Morgan Stanley | Joseph Moore | $109 → $87 | Maintains | Equal-Weight | Get Alert |
| 11/03/2022 | Buy Now | -20.34% | Raymond James | Melissa Fairbanks | $130 → $100 | Maintains | Outperform | Get Alert |
| 11/03/2022 | Buy Now | -32.29% | Rosenblatt | Kevin Cassidy | $110 → $85 | Maintains | Neutral | Get Alert |
| 11/03/2022 | Buy Now | -20.34% | Piper Sandler | Harsh Kumar | $115 → $100 | Maintains | Overweight | Get Alert |
| 11/03/2022 | Buy Now | -28.31% | JP Morgan | Bill Peterson | $125 → $90 | Downgrade | Overweight → Underweight | Get Alert |
| 10/24/2022 | Buy Now | -28.31% | Barclays | Blayne Curtis | $120 → $90 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 10/18/2022 | Buy Now | -36.28% | Cowen & Co. | Matthew Ramsay | $100 → $80 | Maintains | Market Perform | Get Alert |
| 10/11/2022 | Buy Now | -32.29% | Wells Fargo | Gary Mobley | → $85 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 09/13/2022 | Buy Now | — | Exane BNP Paribas | Karl Ackerman | — | Initiates | → Neutral | Get Alert |
| 08/04/2022 | Buy Now | -16.36% | Mizuho | Vijay Rakesh | $110 → $105 | Maintains | Neutral | Get Alert |
| 08/04/2022 | Buy Now | -13.18% | Morgan Stanley | Joseph Moore | $120 → $109 | Maintains | Equal-Weight | Get Alert |
| 08/04/2022 | Buy Now | -4.41% | UBS | Timothy Arcuri | $135 → $120 | Maintains | Neutral | Get Alert |
| 08/04/2022 | Buy Now | -12.38% | Rosenblatt | Kevin Cassidy | $135 → $110 | Maintains | Neutral | Get Alert |
| 08/04/2022 | Buy Now | 3.55% | Raymond James | Melissa Fairbanks | $155 → $130 | Maintains | Outperform | Get Alert |
| 08/04/2022 | Buy Now | -0.43% | JP Morgan | Harlan Sur | $140 → $125 | Maintains | Overweight | Get Alert |
| 08/04/2022 | Buy Now | -8.4% | Piper Sandler | Harsh Kumar | $135 → $115 | Maintains | Overweight | Get Alert |
| 07/25/2022 | Buy Now | -4.41% | Barclays | Blayne Curtis | $135 → $120 | Maintains | Overweight | Get Alert |
| 07/11/2022 | Buy Now | 3.55% | Wells Fargo | Gary Mobley | $175 → $130 | Maintains | Overweight | Get Alert |
| 07/11/2022 | Buy Now | -13.97% | Cowen & Co. | Karl Ackerman | $150 → $108 | Downgrade | Outperform → Market Perform | Get Alert |
| 06/29/2022 | Buy Now | -24.33% | B of A Securities | Vivek Arya | $125 → $95 | Downgrade | Neutral → Underperform | Get Alert |
| 06/21/2022 | Buy Now | -12.38% | Mizuho | Chris Carey | $128 → $110 | Maintains | Neutral | Get Alert |
| 05/05/2022 | Buy Now | -4.41% | Susquehanna | Christopher Rolland | $150 → $120 | Maintains | Neutral | Get Alert |
| 05/05/2022 | Buy Now | 7.54% | UBS | Timothy Arcuri | $145 → $135 | Maintains | Neutral | Get Alert |
| 05/05/2022 | Buy Now | -4.41% | Morgan Stanley | Joseph Moore | $127 → $120 | Maintains | Equal-Weight | Get Alert |
| 05/05/2022 | Buy Now | 7.54% | Needham | Rajvindra Gill | $245 → $135 | Maintains | Buy | Get Alert |
| 05/05/2022 | Buy Now | 1.96% | Mizuho | Vijay Rakesh | $135 → $128 | Maintains | Neutral | Get Alert |
| 05/05/2022 | Buy Now | 23.47% | Raymond James | Chris Caso | $180 → $155 | Maintains | Outperform | Get Alert |
| 05/05/2022 | Buy Now | 7.54% | Rosenblatt | Kevin Cassidy | $170 → $135 | Maintains | Neutral | Get Alert |
| 05/05/2022 | Buy Now | 21.08% | Benchmark | Cody Acree | → $152 | Assumes | → Buy | Get Alert |
| 05/05/2022 | Buy Now | 39.4% | Wells Fargo | Gary Mobley | $185 → $175 | Maintains | Overweight | Get Alert |
| 05/05/2022 | Buy Now | 7.54% | Piper Sandler | Harsh Kumar | $190 → $135 | Maintains | Overweight | Get Alert |
| 05/02/2022 | Buy Now | 1.16% | Morgan Stanley | Joseph Moore | $150 → $127 | Maintains | Equal-Weight | Get Alert |
| 04/25/2022 | Buy Now | 15.5% | Barclays | Blayne Curtis | $200 → $145 | Maintains | Overweight | Get Alert |
| 04/18/2022 | Buy Now | 7.54% | Mizuho | Vijay Rakesh | $155 → $135 | Maintains | Neutral | Get Alert |
FAQ
What is the target price for Qorvo (QRVO) stock?
The latest price target for Qorvo (NASDAQ:QRVO) was reported by Susquehanna on July 17, 2024. The analyst firm set a price target for $145.00 expecting QRVO to rise to within 12 months (a possible 15.50% upside). 38 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Qorvo (QRVO)?
The latest analyst rating for Qorvo (NASDAQ:QRVO) was provided by Susquehanna, and Qorvo maintained their neutral rating.
When was the last upgrade for Qorvo (QRVO)?
The last upgrade for Qorvo Inc happened on December 8, 2023 when Morgan Stanley raised their price target to $134. Morgan Stanley previously had an equal-weight for Qorvo Inc.
When was the last downgrade for Qorvo (QRVO)?
The last downgrade for Qorvo Inc happened on January 4, 2024 when Piper Sandler changed their price target from N/A to $120 for Qorvo Inc.
When is the next analyst rating going to be posted or updated for Qorvo (QRVO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Qorvo, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Qorvo was filed on July 17, 2024 so you should expect the next rating to be made available sometime around July 17, 2025.
Is the Analyst Rating Qorvo (QRVO) correct?
While ratings are subjective and will change, the latest Qorvo (QRVO) rating was a maintained with a price target of $95.00 to $145.00. The current price Qorvo (QRVO) is trading at is $125.54, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.